Kolexia
Maurier Anaïs Pharmacien
Maurier Anaïs
Pharmacien
Centre hospitalier de Tours
Tours, France
21 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Perte d'audition Thrombopénie Paralysie faciale Effets secondaires indésirables des médicaments Paralysie Atteinte rénale aigüe Syndrome coronarien aigu Hémorragie

Collaborateurs

Voir plus
Jonville-Bera Annie-Pierre
Jonville-Bera Annie-Pierre
Centre hospitalier de Tours, Tours, France
Simon Corinne
Simon Corinne
Centre hospitalier de Tours, Tours, France
Largeau Berenger
Largeau Berenger
Centre hospitalier de Tours, Tours, France
Grandvuillemin-Venet Aurelie
Grandvuillemin-Venet Aurelie
Hôpital François Mitterrand, Dijon, France

Industries

Voir plus
MSD
1 collaboration(s)
Dernière en 2016
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Indication for a Pneumocystis Prophylaxis Therapy in Patients with Vascular Anomalies Treated with PIK3/AKT/mTOR Pathway Inhibitors: Experts' Opinion and Systematic Review from the Literature.
Dermatology (Basel, Switzerland)   04 octobre 2023
Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database.
JMIR public health and surveillance   14 juillet 2023
Sudden sensorial hearing loss following mRNA COVID-19 vaccines and safety signal generation: National cross-sectional audiogram-based study
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Response to Letter "Only blames SARS-CoV-2 vaccination for facial palsy after alternative etiologies have been ruled out".
Therapie   25 mai 2023
Pneumocystis prophylaxis therapy in patients with vascular anomalies treated with PIK3/AKT/mTOR pathway inhibitors: Experts’ opinion and systematic review
22nd ESPD Congress, 4–6 May 2023   23 avril 2023
Peripheral facial palsy post SARS-CoV-2 vaccine: A regional pharmacovigilance cases series.
Therapie   16 février 2023
Sex differences in adverse drug reactions: Are women more impacted?
Therapie   07 octobre 2022
Adverse effects of gender-affirming hormonal therapy in transgender persons: Assessing reports in the French pharmacovigilance database.
Fundamental & clinical pharmacology   06 juin 2022
Les effets indésirables du traitement hormonal chez les personnes transgenres : analyse des cas rapportés dans la base de données nationale de pharmacovigilance
37ème Congrès de la Société Française d’Endocrinologie - Le Havre 2021   01 octobre 2021
Intravascular pulmonary migration of Nexplanon®: a new side effect for an old product
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 15–16 June 2021, E‐meeting, France   02 juin 2021